Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4726 AL 4740

Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer's Disease

Padhi D, Govindaraju T.

J Med Chem. 2022 May 26;65(10):7088-7105. doi: 10.1021/acs.jmedchem.2c00335. Epub 2022 May 13.

The Broad Range of Research in Alzheimer's Disease and Related Dementias

DeKosky ST, Duara R.

Neurotherapeutics. 2022 Jan;19(1):1-7. doi: 10.1007/s13311-022-01245-4. Epub 2022 May 13.

Antidiabetic Drugs in the Treatment of Alzheimer's Disease

Michailidis M, Tata DA, Moraitou D, Kavvadas D, Karachrysafi S, Papamitsou T, Vareltzis P, Papaliagkas V.

Int J Mol Sci. 2022 Apr 22;23(9):4641. doi: 10.3390/ijms23094641.

The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer's Disease

Wiatrak B, Balon K, Jawień P, Bednarz D, Jęśkowiak I, Szeląg A.

Int J Mol Sci. 2022 Apr 27;23(9):4862. doi: 10.3390/ijms23094862.

Stress-Induced Depression and Alzheimer's Disease: Focus on Astrocytes

Dolotov OV, Inozemtseva LS, Myasoedov NF, Grivennikov IA.

Int J Mol Sci. 2022 Apr 30;23(9):4999. doi: 10.3390/ijms23094999.

A(2A) Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?

Merighi S, Nigro M, Travagli A, Pasquini S, Borea PA, Varani K, Vincenzi F, Gessi S.

Int J Mol Sci. 2022 May 2;23(9):5056. doi: 10.3390/ijms23095056.

A Narrative Review of the Effects of Citrus Peels and Extracts on Human Brain Health and Metabolism

Matsuzaki K, Nakajima A, Guo Y, Ohizumi Y.

Nutrients. 2022 Apr 28;14(9):1847. doi: 10.3390/nu14091847.

Do Sleep Disturbances have a Dual Effect on Alzheimer's Disease?

Arjmandi-Rad S, Ebrahimnejad M, Zarrindast MR, Vaseghi S.

Cell Mol Neurobiol. 2023 Mar;43(2):711-727. doi: 10.1007/s10571-022-01228-1. Epub 2022 May 14.

Molecular Insights into Cell Type-specific Roles in Alzheimer's Disease: Human Induced Pluripotent Stem Cell-based Disease Modelling

Qu W, Canoll P, Hargus G.

Neuroscience. 2023 May 10;518:10-26. doi: 10.1016/j.neuroscience.2022.05.006. Epub 2022 May 13.

Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders

Agnihotri TG, Jadhav GS, Sahu B, Jain A.

Drug Deliv Transl Res. 2022 Dec;12(12):3104-3120. doi: 10.1007/s13346-022-01173-y. Epub 2022 May 15.

Microbiota-gut-brain axis in the Alzheimer's disease pathology - an overview

Giridharan VV, Barichello De Quevedo CE, Petronilho F.

Neurosci Res. 2022 Aug;181:17-21. doi: 10.1016/j.neures.2022.05.003. Epub 2022 May 14.

Brexpiprazole-Associated Pisa Syndrome (Pleurothotonus) in a Patient With Dementia

Nagai Y, Yamazaki T, Sugita T, Shibata N.

Clin Neuropharmacol. 2022 May-Jun 01;45(3):72-73. doi: 10.1097/WNF.0000000000000500. Epub 2022 Apr 14.

The amyloid precursor protein: a converging point in Alzheimer's disease

Delport A, Hewer R.

Mol Neurobiol. 2022 Jul;59(7):4501-4516. doi: 10.1007/s12035-022-02863-x. Epub 2022 May 17.

A novel approach to type 3 diabetes mechanism: The interplay between noncoding RNAs and insulin signaling pathway in Alzheimer's disease

Moayedi K, Orandi S, Ebrahimi R, Tanhapour M, Moradi M, Abbastabar M, Golestani A.

J Cell Physiol. 2022 Jul;237(7):2838-2861. doi: 10.1002/jcp.30779. Epub 2022 May 17.

Are mitophagy enhancers therapeutic targets for Alzheimer's disease?

Pradeepkiran JA, Hindle A, Kshirsagar S, Reddy PH.

Biomed Pharmacother. 2022 May;149:112918. doi: 10.1016/j.biopha.2022.112918. Epub 2022 Apr 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias